Bobby Junior, wrong again

“A widely debated question deserves more than headlines—it
deserves robust evidence,” first author Hoda Tayebi Hillali, DDS, MSc, of the
University of Santiago de Compostela, in Spain, said in a press release from Wiley, publisher
of the journal that posted the study. “Our findings show that the apparent
association between prenatal paracetamol [acetaminophen] exposure and autism or
ADHD weakens as methodological quality improves, challenging the interpretation
of a causal link and supporting evidence-based decisions during
pregnancy.”
Acetaminophen ‘appropriate first-line treatment’
The umbrella review, published in Developmental Medicine
& Child Neurology, included data from seven meta-analyses that involved
more than 3 million participants. While unrestricted evaluation showed a slight
association between moms using acetaminophen and a child’s autism or ADHD
risk—a risk ratio of 1.17 and 1.29, respectively—when examining high-quality
data the relationship no longer existed.
“The observed associations between prenatal paracetamol
exposure and neurodevelopmental disorders are probably influenced by
methodological limitations,” the authors wrote. “Current epidemiological
evidence does not support a robust causal relationship, and paracetamol remains
an appropriate first-line treatment during pregnancy when clinically
indicated.”
The findings of this review reinforce what past research suggests about maternal acetaminophen use and autism or ADHD diagnoses in children.
A study
from June in JAMA Internal Medicine found no association between
moms who use the medication—one of the few pain and fever relievers that can be
used in pregnancy—and their child being diagnosed as having neurodevelopmental
conditions. Additionally, another umbrella
review and a Danish national study
also uncovered no relationship between mothers’ use acetaminophen and their
children’s diagnoses with autism or ADHD.
“At present, the available epidemiological evidence does not
support changes to existing prescribing recommendations when considering the
balance of risks and benefits, taking into account the potential consequences
of untreated maternal fever, pain, or inflammatory conditions during
pregnancy,” the authors wrote.